Godrej Agrovet Ltd (GODREJAGRO) is currently trading at 593.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Godrej Agrovet is a diversified agribusiness group operating five core verticals: animal nutrition (cattle, poultry, aquafeed), crop protection (in‑house and in‑licensed chemistries), oil palm plantations and downstream edible/ specialty fats, dairy (Creamline/Godrej Jersey), and processed/frozen foods (Godrej Foods/Yummiez and related brands). The group also houses Astec LifeSciences as an integrated CDMO and formulation player within the portfolio. Q1 FY27 performance showed revenue growth of 10% to INR2,852 crore driven by robust Animal Nutrition (+12.6% revenue, 15% cattle feed volume growth) and Oil Palm (+28.9% revenue) while Crop Care was notably impacted by a delayed monsoon; Astec returned to EBITDA breakeven and Bangladesh JV resumed double‑digit volume and PBT growth, reflecting improved operational execution. The company is shifting Oil Palm from a pure upstream model to a fully integrated value‑added player: commissioning an integrated palm complex and specialty fats refinery, targeting downstream product conversion and an expected structural uplift of roughly 200 basis points to consolidated EBITDA when scaled, while maintaining a disciplined capex IRR threshold of ~16–18%. Godrej Foods is being repositioned aggressively toward higher‑quality B2C branded frozen foods and protein products: Yummiez and other NPDs are growing 20%–28% in volumes, frozen chicken and momos are category creation bets, and management plans to reduce live bird trading to focus on branded higher‑margin offerings across a national distribution effort. Crop Protection is in active portfolio diversification after a weak monsoon‑affected quarter: new launches (Ashitaka, Takai, Ghassnash) scaled rapidly, contributing materially to sales mix (management indicated Ashitaka+Takai contributing ~18–20% of Q1 segment sales), illustrating a strategic move away from heavy cotton herbicide concentration toward multi‑crop productization and in‑licensing partnerships.

Over the past 52 weeks, Godrej Agrovet Ltd has traded between a low of ₹506.70 and a high of ₹698.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Godrej Agrovet Ltd has a market capitalization of approximately 11,812.14. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Godrej Agrovet Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 27.82 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 11,812.14 Cr, Godrej Agrovet Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Godrej Agrovet Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Godrej Agrovet Ltd is 27.82. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Godrej Agrovet reported consolidated net profit of ₹128.3 crore for Q1 FY27, down 13.8% from ₹149 crore in Q1 FY26.

The provided snapshot lists Godrej Agrovet’s share price at ₹596.30 as on April 30, 2026.

Godrej Agrovet announced its Q4 FY26 financial results on April 30, 2026, as per NSE and BSE exchange filings.

FY26 revenue was ₹10,232.68 crore and PAT was ₹445.18 crore, compared with ₹9,382.77 crore revenue and ₹403.37 crore PAT in FY25.